Document Detail

Management of sepsis during Mars treatment in acute on chronic liver failure.
MedLine Citation:
PMID:  21620059     Owner:  NLM     Status:  In-Data-Review    
INTRODUCTION: The aim of our study was a 30-day follow-up of the use of early detection of endotoxin by the endotoxin activity assay (EAA) for patients with acute liver failure superimposed on chronic liver disease (AoCLF) and treated with polymyxin-B hemoperfusion-based (PMX-DHP) treatment and albumin dialysis in the molecular adsorbent recirculating system (MARS).
MATERIALS AND METHODS: From February 2008 to July 2010, we evaluated 10 AoCLF patients experiencing systemic inflammatory response syndrome (SIRS) in association with suspected infection and an EAA-positive test (>0.60). These patients awaiting liver transplantation (OLT) showed similar Model End-Stage Liver Disease (MELD) scores (range, 19-25) and encephalopathy grade ≤ 2. Five patients received therapy to remove endotoxins with PMX-DHP with MARS treatment for liver failure (group A); the other 5 patients received MARS treatment only (group B).
RESULTS: Two PMX-DHP treatments were performed in 4 group A patients (average EA = 0.66 [range, 0.61-0.70]) and 3 treatments for 1 patient (EA = 0.92). All 5 subjects underwent an average of 4 MARS treatments (range, 3-5). At the end of therapy, the median EA level was 0.42 (range, 0.37-0.48). As reported in the literature, we achieved a significant improvement in liver and kidney functions using MARS. Measurements of lactate, interleukin (IL)-6, and tumor necrosis factor (TNF)-α were significantly improved among patients treated with the extracorporeal therapies. At 30 days of observation, all 5 patients treated with MARS plus PMX-DHP are alive. In group B, a mean of 7.5 MRAS treatments were performed. We observed an improvement in hemodynamic and liver functions with reduced levels of proinflammatory cytokines and lactates in 4 patients. One patient showed no improvement in clinical status with the development of sepsis and subsequent multiorgan failure after 24 days.
CONCLUSION: The possibility of an early diagnosis using the EAA in AoCLF patients could prevent the progression of the sepsis cascade. The use of PMX-DHP and MARS in these patients, could lead to resolution of clinical status in a short time.
G Novelli; V Morabito; F Pugliese; G Ferretti; S Novelli; S Ianni; Q Lai; M Rossi; P B Berloco
Related Documents :
18467619 - Aminaphtone in idiopathic cyclic oedema syndrome.
19488589 - Eccentric strength and endurance in patients with unilateral intermittent claudication.
11298619 - Sympathetic autoregulation in peripheral vascular disease.
8405489 - Percutaneous angioplasty of the profunda femoris artery: a safe and effective endovascu...
22459399 - Prevalence, risk, and benefits of radiofrequency catheter ablation at the aortic cusp f...
21911809 - Detection of intimal defect by 64-row multidetector computed tomography in patients wit...
6093679 - Dna analysis in patients with hereditary fructose intolerance.
24431329 - A novel immunodeficiency syndrome associated with partial trisomy 19p13.
10091409 - Detection of focal myeloma lesions by technetium-99m-sestamibi scintigraphy.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Transplantation proceedings     Volume:  43     ISSN:  1873-2623     ISO Abbreviation:  Transplant. Proc.     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-05-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0243532     Medline TA:  Transplant Proc     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1085-90     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 Elsevier Inc. All rights reserved.
Dipartimento "P. Stefanini," Chirurgia Generale e Trapianti d'Organo, Sapienza Università di Roma, Rome, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Intensive care unit admission of decompensated cirrhotic patients: prognostic scoring systems.
Next Document:  Microwave thermal ablation for hepatocarcinoma: six liver transplantation cases.